Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (141-150 of 420) with videos related to

Pageof 42
Sort By:
American Journal of Hematology|May 7, 2016
Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remissionOfir Wolach, Kristen E Stevenson, Martha Wadleigh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for InterventionAndrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Journal of the National Cancer Institute|March 22, 2024
Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemiaAndrew Hantel, Andrew M Brunner, Jesse J Plascak, et al.
Leukemia Research|June 19, 2013
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)Eyal C Attar, Philip C Amrein, James W Fraser, et al.
Leukemia Research|June 24, 2011
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutationsHarshabad Singh, Salma Asali, Lillian L Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patientsAnn Cai, Derin B Keskin, David S DeLuca, et al.
Haematologica|April 23, 2026
Prevalence and impact of frailty assessed using standard geriatrics tools in older adults with blood cancersClark DuMontier, Angel M Cronin, Tammy T Hshieh, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
British Journal of Haematology|August 2, 2016
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemiaBhavana Bhatnagar, Ann-Kathrin Eisfeld, Deedra Nicolet, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Pageof 42

Showing results (141-150 of 420) with videos related to

Sort By:
Pageof 42
American Journal of Hematology|May 7, 2016
Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remissionOfir Wolach, Kristen E Stevenson, Martha Wadleigh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for InterventionAndrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Journal of the National Cancer Institute|March 22, 2024
Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemiaAndrew Hantel, Andrew M Brunner, Jesse J Plascak, et al.
Leukemia Research|June 19, 2013
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)Eyal C Attar, Philip C Amrein, James W Fraser, et al.
Leukemia Research|June 24, 2011
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutationsHarshabad Singh, Salma Asali, Lillian L Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patientsAnn Cai, Derin B Keskin, David S DeLuca, et al.
Haematologica|April 23, 2026
Prevalence and impact of frailty assessed using standard geriatrics tools in older adults with blood cancersClark DuMontier, Angel M Cronin, Tammy T Hshieh, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
British Journal of Haematology|August 2, 2016
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemiaBhavana Bhatnagar, Ann-Kathrin Eisfeld, Deedra Nicolet, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Pageof 42